Silo Pharma prices USD 4 million at-the-market private placement of 619,965 shares

Silo Pharma Inc

Silo Pharma Inc

SILO

0.00
  • Silo Pharma priced an at-the-market private placement to raise USD 4 million in gross proceeds.
  • Deal covers 619,965 common shares or pre-funded warrants at USD 6.45 each, bundled with Series A-3 and Series A-4 warrants.
  • Warrants carry a USD 6.21 exercise price, implying up to USD 7.7 million of additional gross proceeds if fully exercised for cash.
  • H.C. Wainwright is the exclusive placement agent; closing expected on or about July 10, 2026.
  • Proceeds earmarked for working capital and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief on July 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.